News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,699 Results
Type
Article (42619)
Company Profile (276)
Press Release (688789)
Multimedia
Podcasts (86)
Webinars (21)
Section
Business (205986)
Career Advice (2087)
Deals (35730)
Drug Delivery (122)
Drug Development (81625)
Employer Resources (175)
FDA (16527)
Job Trends (15114)
News (348437)
Policy (32963)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2667)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49994)
ALS (193)
Alzheimer's disease (1746)
Antibody-drug conjugate (ADC) (367)
Approvals (16840)
Artificial intelligence (610)
Autoimmune disease (226)
Automation (52)
Bankruptcy (365)
Best Places to Work (11696)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (178)
Bladder cancer (177)
Brain cancer (63)
Breast cancer (689)
Cancer (5319)
Cardiovascular disease (443)
Career advice (1771)
Career pathing (39)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (800)
Cervical cancer (41)
Clinical research (70295)
Collaboration (1906)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2757)
CRISPR (100)
C-suite (977)
Cystic fibrosis (148)
Data (7056)
Decentralized trials (3)
Denatured (27)
Depression (152)
Dermatology (58)
Diabetes (549)
Diagnostics (6949)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (300)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (91245)
Editorial (60)
Employer branding (22)
Employer resources (154)
Events (118923)
Executive appointments (1038)
FDA (19947)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1622)
Gene editing (212)
Generative AI (54)
Gene therapy (656)
GLP-1 (1021)
Government (4725)
Grass and pollen (6)
Guidances (396)
Healthcare (19024)
HIV (75)
Huntington's disease (53)
IgA nephropathy (91)
Immunology and inflammation (273)
Immuno-oncology (80)
Indications (157)
Infectious disease (3071)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (130)
Intellectual property (274)
Interviews (322)
IPO (16690)
IRA (50)
Job creations (3732)
Job search strategy (1479)
JPM (58)
Kidney cancer (18)
Labor market (93)
Layoffs (560)
Leadership (38)
Legal (8000)
Liver cancer (98)
Longevity (29)
Lung cancer (716)
Lymphoma (406)
Machine learning (53)
Management (59)
Manufacturing (922)
MASH (176)
Medical device (13931)
Medtech (14009)
Mergers & acquisitions (20200)
Metabolic disorders (1408)
mRNA (176)
Multiple sclerosis (172)
NASH (18)
Neurodegenerative disease (381)
Neuropsychiatric disorders (97)
Neuroscience (3142)
Neurotech (1)
NextGen: Class of 2026 (6588)
Non-profit (4576)
Now hiring (73)
Obesity (663)
Opinion (283)
Ovarian cancer (185)
Pain (228)
Pancreatic cancer (254)
Parkinson's disease (339)
Partnered (33)
Patents (553)
Patient recruitment (587)
Peanut (60)
People (59628)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (21912)
Phase 2 (30956)
Phase 3 (23046)
Pipeline (7110)
Policy (303)
Postmarket research (2570)
Preclinical (9321)
Press Release (69)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (304)
Rare diseases (991)
Real estate (6102)
Recruiting (71)
Regulatory (25114)
Reports (54)
Research institute (2483)
Resumes & cover letters (357)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (269)
Series B (201)
Service/supplier (13)
Sickle cell disease (106)
Special edition (23)
Spinal muscular atrophy (164)
Sponsored (46)
Startups (3679)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (57)
Vaccines (1058)
Venture capital (99)
Weight loss (420)
Women's health (110)
Worklife (20)
Date
Last 7 days (637)
Last 30 days (2454)
Last 365 days (30016)
2026 (8015)
2025 (30315)
2024 (35366)
2023 (40251)
2022 (51418)
2021 (55935)
2020 (54413)
2019 (46906)
2018 (35250)
2017 (32447)
2016 (31876)
2015 (37858)
2014 (31620)
2013 (26712)
2012 (28896)
2011 (29579)
2010 (27546)
Location
Africa (760)
Alabama (90)
Alaska (7)
Arizona (333)
Arkansas (13)
Asia (39907)
Australia (6504)
California (12289)
Canada (3519)
China (1233)
Colorado (523)
Connecticut (522)
Delaware (367)
Europe (86089)
Florida (1849)
Georgia (400)
Hawaii (3)
Idaho (63)
Illinois (956)
India (80)
Indiana (562)
Iowa (23)
Japan (487)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1483)
Massachusetts (8791)
Michigan (346)
Minnesota (677)
Mississippi (6)
Missouri (139)
Montana (33)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3281)
New Mexico (29)
New York (3251)
North Carolina (1557)
North Dakota (9)
Northern California (6066)
Ohio (376)
Oklahoma (23)
Oregon (41)
Pennsylvania (2484)
Puerto Rico (26)
Rhode Island (50)
South America (1135)
South Carolina (76)
South Dakota (1)
Southern California (4837)
Tennessee (199)
Texas (1928)
United States (43560)
Utah (372)
Vermont (1)
Virginia (294)
Washington D.C. (80)
Washington State (985)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
731,699 Results for "harmony labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
·
1 min read
Press Releases
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
April 2, 2026
·
4 min read
Press Releases
Harmony Biosciences to Participate in Upcoming March 2026 Investor Conferences
March 4, 2026
·
1 min read
Rare diseases
Harmony Fails Pivotal Fragile X Syndrome Trial, Blames High Placebo Response
While Harmony management has not disclosed future plans for ZYN002, Jefferies analysts expect the asset to be shelved.
September 25, 2025
·
1 min read
·
Tristan Manalac
Rare diseases
Harmony Freezes Cannabidiol Gel After Phase III Miss in Fragile X Syndrome
Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug failed to significantly improve social avoidance in a late-stage study in fragile X Syndrome.
November 5, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Harmony’s Dravet Drug Halves Monthly Seizures in Late-Stage Study
The Phase III, open-label extension study suggests EPX-100 has a “positive” risk/benefit profile for the treatment of Dravet syndrome, analysts at H.C. Wainwright & Co. said Tuesday.
December 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
March 9, 2026
·
9 min read
Press Releases
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
·
1 min read
Press Releases
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
February 24, 2026
·
20 min read
Press Releases
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
1 of 73,170
Next
